Our study found that the activation of ALOX12–12-HETE was further enhanced in NAFLD during IRI than the normal livers, and the inhibition of ALOX12 by ML355 decreased 12HETE levels. The gene discussed is ALOX12; the disease is metabolic dysfunction-associated steatotic liver disease.